[1]
S. P. Karande, R. P. Munshi, and D. A. Kumbhar, “A double blind, randomized, placebo controlled, phase IV, proof-of-concept, comparative study to evaluate the efficacy and safety of Swasawin asthaloc tablets when given as add-on therapy in patients suffering from mild to moderate persistent bronchial asthma”, Int J Res Med Sci, vol. 5, no. 11, pp. 4929–4936, Oct. 2017.